Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000626757 | SCV000747460 | uncertain significance | Myopia; Soft skin; Poor wound healing; Striae distensae; Joint hypermobility; Gastroesophageal reflux; Thoracic scoliosis; Spontaneous hematomas | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001270167 | SCV001370187 | uncertain significance | Brittle cornea syndrome 1 | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The following ACMG criteria were applied in classifying this variant: PM2. |
Ambry Genetics | RCV002457966 | SCV002738874 | uncertain significance | Cardiovascular phenotype | 2022-03-09 | criteria provided, single submitter | clinical testing | The p.N857D variant (also known as c.2569A>G), located in coding exon 1 of the ZNF469 gene, results from an A to G substitution at nucleotide position 2569. The asparagine at codon 857 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |